Table 4.
Comparison of clinical parameters analyzed and particular genotypes of the -197G > A IL-17 polymorphism in healthy women after menopause
| Parameter/genotype | GG | GA | AA |
|---|---|---|---|
| T-score | −0.19 ± 0.49 | −0.01 ± 0.72 | 0.32 ± 0.47 |
| Z-score | 0.60 ± 0.93 | 0.63 ± 0.87 | 0.70 ± 0.72 |
| Body mass (kg) | 70.33 ± 9.80 | 67.07 ± 9.81 | 67.13 ± 8.56 |
| Height (cm) | 163.04 ± 5.66 | 163.58 ± 6.02 | 163.97 ± 5.92 |
| Body mass index (kg/m2) | 25.07 ± 4.07 | 25.73 ± 3.80 | 25.10 ± 4.40 |
| Age | 52.03 ± 7.60 | 50.32 ± 8.02 | 54.68 ± 7.90 |
| Birth weight | 3552.83 ± 517.35 | 3506.79 ± 440.31 | 3708.44 ± 501.71 |
| Reproductive years | 36.63 ± 5.06 | 36.04 ± 4.72 | 35.36 ± 4.77 |
| Age of menarche | 12.78 ± 1.68 | 13.92 ± 1.69 | 13.83 ± 1.88 |
| Last menstrual period age | 50.17 ± 4.58 | 52.16 ± 4.04 | 51.03 ± 5.03 |
| Number of pregnancies | 2.10 ± 1.06 | 2.06 ± 1.50 | 1.87 ± 1.26 |
| Years after menopause | 7.45 ± 6.06 | 7.58 ± 5.47 | 7.90 ± 6.15 |
| BMD L2–L4 (g/cm2) | 1.14 ± 0.09 | 1.26 ± 0.15 | 1.24 ± 0.11 |
| BMD L2–L4 YA (%) | 93.45 ± 8.57 | 99.52 ± 8.06 | 106.24 ± 7.52 |
| BMD L2–L4 AM (%) | 100.02 ± 9.12 | 106.30 ± 10.02 | 109.56 ± 9.52 |